VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company continues to see rising revenues and profitability. In the nine months ended September 30, 2024, revenue increased by 58% year over year to $3,364,635 and gross profit increased by 84% to $1,290,357.In the three months ended September 30, 2024, revenue increased by 25% year over year to $1,195,122 and gross
Health
